BioXcel Therapeutics (BTAI) Change in Account Payables (2018 - 2019)
BioXcel Therapeutics (BTAI) posted quarterly Change in Account Payables of $4000.0 for Q1 2019, down 69.23% year-over-year from $13000.0 in Q1 2018, and down 69.23% quarter-over-quarter from $13000.0 in Q1 2018.
BioXcel Therapeutics (BTAI) Change in Account Payables (2018 - 2019) Analysis & Trends
BioXcel Therapeutics' Change in Account Payables history runs 2 years deep, the most recent figure standing at $4000.0 for Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.52 Mn | 24.52 Mn | 160,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |